Capricor Therapeutics, Inc.
CAPR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001133869
No open-market purchases or sales by Capricor Therapeutics, Inc. insiders were filed in the last 90 days; 169 institutions reported holding it in 13F filings for Q2 2026, worth $941.6M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Capricor Therapeutics, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 30 | 25 | −5 |
| Shares | 2.49M | 2.32M | −170.7K (−6.9%) |
| Value | $10.0M | $6.80M | −$3.23M (−32.2%) |
New holders (3)
Institutions that held Capricor Therapeutics, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jump Financial, LLC | 22,800 | $67.0K | 0.00% |
| UBS Group AG | 3,748 | $11.0K | 0.00% |
| Tyler-Stone Wealth Management | 90 | $0 | 0.00% |
Sold out (8)
Institutions that held Capricor Therapeutics, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Gsa Capital Partners LLP | 96,632 | $388.0K |
| Virtu Financial LLC | 55,200 | $222.0K |
| HighTower Advisors, LLC | 53,960 | $215.0K |
| Two Sigma Securities, LLC | 11,511 | $46.0K |
| Barclays PLC | 6,330 | $25.0K |
| Bank of America Corp | 337 | $1.00K |
| FMR LLC | 40 | $0 |
| Total Clarity Wealth Management, Inc. | 75 | $0 |